Bursicon receptor gene HLGR2 as a potential RNA interference target for control of the fall webworm Hyphantria protein-coupled receptors (GPCRs) have been identified as a new generation of attractive targets for RNA Results: The complementary DNA (cDNA) sequence and deduced amino acids of HLGR2 were obtained and analyzed HLGR2 is a typical GPCR and shows high structural and sequence similarity with other insect LGR2 proteins

September 2022 Regulator of G Protein Signaling 20 Correlates with Long Intergenic Non-Coding RNA (lincRNAs significantly associated with some tumor-related signaling pathways and long intergenic non-coding RNAs

September 2022 "RNA editing is a process by which post-transcriptional changes of mRNA nucleotides alter The 5HT2C serotonin receptor, which undergoes 32 distinct RNA-editing events leading to 24 protein isoforms To elucidate the molecular mechanisms responsible for these effects of RNA editing, we present four active-state findings reveal a unique hydrogen-bonding network located on intracellular loop 2 that is subject to RNA

Objective: In the present study, the RNA-Seq whole transcriptome of renal transplant (RT) patients was using RNA-Seq. The resulted raw data were analyzed by conventional RNA-Seq software to determine the Differentially The results were in consistent with RNA-Seq resultsoutcomes. Tags Human cytomegalovirus , Indirect effects , RNA-Seq , Renal transplantation , Transcriptome .

breast cancer cell pools with normal or reduced ability to respond to progesterone: a study based on RNA-seq Differentially expressed (DE) genes between experimental groups were characterized based on RNA-seq and Nathalie Schuster , Stefan Aebi , Rolf Jaggi Tags Breast cancer cell pools , progesterone response , RNA-seq

Immunology Unveiling G-protein coupled receptors as potential targets for ovarian cancer nanomedicines: from RNA sequencing data analysis to in vitro validation Published date July 27, 2024 Abstract "Genetic heterogeneity Here we report on the systematic analysis of public ribonucleic acid-sequencing (RNA-seq) gene expression , Hugo Albrecht Tags Drug delivery , GPCR , Nanomedicine , Ovarian cancer , Personalised medicine , RNA-seq